The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality
Open accessAbstract
OBJECTIVE: To assess the efficacy and safety of pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of baseline hypoalbuminaemia) in critically unwell adults with sepsis of any severity. DESIGN: Systematic review and meta-analysis of randomised clinical trials, with trial sequential analysis, subgroup, and meta-regression analyses. DATA SOURCES: PubMed, PubMed Central, Web of Science (includes Medline, Conference Proceedings Citation Index, Data Citation Index, Chinese Science Citation Database, CAB abstracts, Derwent Innovations Index), OvidSP (includes Embase, Ovid Medline, HMIC, PsycINFO, Maternity and Infant Care, Transport Database), Cochrane Library, clinicaltrials.gov, controlled-trials.com, online material, relevant conference proceedings, hand searching of reference lists, and contact with authors as necessary. ELIGIBILITY CRITERIA: Prospective randomised clinical trials of adults with sepsis of any severity (with or without baseline hypoalbuminaemia) in critical or intensive care who received pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of hypoalbuminaemia) compared with those who received control fluids (crystalloid or colloid), were included if all-cause mortality outcome data were available. No restriction of language, date, publication status, or primary study endpoint was applied. DATA EXTRACTION: Two reviewers independently assessed articles for inclusion, extracted data to assess risk of bias, trial methods, patients, interventions, comparisons, and outcome. The relative risk of all-cause mortality was calculated using a random effects model accounting for clinical heterogeneity. PRIMARY OUTCOME MEASURE: All-cause mortality at final follow-up. RESULTS: Eighteen articles reporting on 16 primary clinical trials that included 4190 adults in critical or intensive care with sepsis, severe sepsis, or septic shock. A median of 70.0 g daily of pooled human albumin was received over a median of 3 days by adults with a median age of 60.8 years as part of fluid volume expansion and resuscitation, with or without correction of hypoalbuminaemia. The relative risk of death was similar between albumin groups (that received a median of 175 g in total) and control fluid groups (relative risk 0.94; 95% confidence interval 0.87 to 1.01; P=0.11; I(2)=0%). Trial sequential analysis corrected the 95% confidence interval for random error (0.85 to 1.02; D(2)=0%). Eighty eight per cent of the required information size (meta-analysis sample size) of 4894 patients was achieved, and the cumulative effect size measure (z score) entered the futility area, supporting the notion of no relative benefit of albumin (GRADE quality of evidence was moderate). Evidence of no difference was also found when albumin was compared with crystalloid fluid (relative risk 0.93; 0.86 to 1.01; P=0.07; I(2)=0%) in 3878 patents (GRADE quality of evidence was high; 79.9% of required information size) or colloid fluids in 299 patients (relative risk 1.04; 0.79 to 1.38; P=0.76; I(2)=0%) (GRADE quality of evidence was very low; 5.8% of required information size). When studies at high risk of bias were excluded in a predefined subgroup analysis, the finding of no mortality benefit remained, and the cumulative z score was just outside the boundary of futility. Overall, the meta-analysis was robust to sensitivity, subgroup, meta-regression, and trial sequential analyses. CONCLUSIONS: In this analysis, human albumin solutions as part of fluid volume expansion and resuscitation for critically unwell adults with sepsis of any severity (with or without baseline hypoalbuminaemia) were not robustly effective at reducing all-cause mortality. Albumin seems to be safe in this setting, as a signal towards harm was not detected, but this analysis does not support a recommendation for use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Boldt, J., Heesen, M. A., Müller, M., Pabsdorf, M., & Hempelmann, G. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199608000-00010 · Cited by 137
RetractedBoldt, J., Müller, M., Heesen, M., Neumann, K., & Hempelmann, G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00005 · Cited by 111
RetractedRETRACTED ARTICLE: Volume therapy in the critically ill: is there a difference?
Boldt, J., Müller, M., Mentges, D., Papsdorf, M., & Hempelmann, G. (1998) · Intensive Care Medicine · doi:10.1007/s001340050511 · Cited by 109
RetractedInfluence of different volume therapies on platelet function in the critically ill
Boldt, J., Müller, M., Heesen, M. A., Heyn, O., & Hempelmann, G. (1996) · Intensive Care Medicine · doi:10.1007/bf01699231 · Cited by 54
RetractedThe SAFE study: saline vs. albumin for fluid resuscitation in the critically ill
Finfer, S., Norton, R., Bellomo, R., Boyce, N., French, J., & Myburgh, J. (2004) · Vox Sanguinis · doi:10.1111/j.1741-6892.2004.00468.x · Cited by 48
RetractedBoldt, J., Heesen, M. A., Welters, I. D., Padberg, W. M., Martin, K. M., & Hempelmann, G. (1995) · British Journal of Anaesthesia · doi:10.1093/bja/75.6.740 · Cited by 47
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Acute Respiratory Distress Syndrome: The Berlin Definition
(2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,731
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa040232 · Cited by 2,872
Sepsis in European intensive care units: Results of the SOAP study*
Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., Carlet, J., Le Gall, J.-R., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,836
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Perner, A., Haase, N., Guttormsen, A. B., Tenhunen, J., Klemenzson, G., Åneman, A., Madsen, K. R., Møller, M. H., Elkjær, J. M., Poulsen, L. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204242 · Cited by 1,813
A prospective randomized trial
(1995) · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · doi:10.4030/jjcs1979.20.2_191 · Cited by 1,619
Sterne, J. A. C. (2001) · BMJ · doi:10.1136/bmj.322.7280.226 · Cited by 1,466
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
Caironi, P., Tognoni, G., Masson, S., Fumagalli, R., Pesenti, A., Romero, M., Fanizza, C., Caspani, L., Faenza, S., Grasselli, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305727 · Cited by 1,324
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309
APACHE II-A Severity of Disease Classification System
Gall, J.-R. L., Loirat, P., & Alpcrovitch, A. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00027 · Cited by 1,236
Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials
LeLorier, J., Grégoire, G., Benhaddad, A., Lapierre, J., & Derderian, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370806 · Cited by 1,171
Colloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., Roberts, I., & Ker, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub6 · Cited by 1,115
Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated
Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.309.6965.1351 · Cited by 1,017
Estimating required information size by quantifying diversity in random-effects model meta-analyses
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-86 · Cited by 938
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G., Ioannidis, J. P. A., Thabane, L., Gluud, L.-L., Als-Nielsen, B., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 833
Schortgen, F., Lacherade, J.-C., Bruneel, F., Cattaneo, I., Hemery, F., Lemaire, F., & Brochard, L. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04211-2 · Cited by 741
Association of serum albumin and mortality risk
Goldwasser, P., & Feldman, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00015-2 · Cited by 716
Vincent, J.-L., Dubois, M.-J., Navickis, R. J., & Wilkes, M. M. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000055547.93484.87 · Cited by 692
Zarychanski, R., Abou-Setta, A. M., Turgeon, A. F., Houston, B. L., McIntyre, L., Marshall, J. C., & Fergusson, D. A. (2013) · JAMA · doi:10.1001/jama.2013.430 · Cited by 649
Influence of trial sample size on treatment effect estimates: meta-epidemiological study
Dechartres, A., Trinquart, L., Boutron, I., & Ravaud, P. (2013) · BMJ · doi:10.1136/bmj.f2304 · Cited by 544
Finfer, S., Liu, B., Taylor, C., Bellomo, R., Billot, L., Cook, D., Du, B., McArthur, C., Myburgh, J., & SAFE TRIPS Investigators (2010) · Critical Care · doi:10.1186/cc9293 · Cited by 420
Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis
The SAFE Study Investigators (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2039-6 · Cited by 399
Rackow, E. C., Falk, J. L., Fein, I. A., Siegel, J., Packman, M. I., Haupt, M. T., Kaufman, B., & Putnam, D. (1983) · PubMed · Cited by 393
Martin, G. S., Moss, M., Wheeler, A. P., Mealer, M., Morris, J. A., & Bernard, G. R. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171539.47006.02 · Cited by 361
Human albumin solution for resuscitation and volume expansion in critically ill patients
Roberts, I., Blackhall, K., Alderson, P., Bunn, F., & Schierhout, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001208.pub4 · Cited by 355
Delaney, A. P., Dan, A., McCaffrey, J., & Finfer, S. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181ffe217 · Cited by 351
Carter, T. (2003) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.1021 · Cited by 343
Dubois, M.-J., Orellana-Jimenez, C., Melot, C., De Backer, D., Berre, J., Leeman, M., Brimioulle, S., Appoloni, O., Creteur, J., & Vincent, J.-L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239119.57544.0c · Cited by 323
Haase, N., Perner, A., Hennings, L. I., Siegemund, M., Lauridsen, B., Wetterslev, M., & Wetterslev, J. (2013) · BMJ · doi:10.1136/bmj.f839 · Cited by 310
Sifting the evidence—what's wrong with significance tests?
Sterne, J. A. C., & Smith, G. D. (2001) · Physical Therapy · doi:10.1093/ptj/81.8.1464 · Cited by 301
Zhang, Z., Xu, X., & Ni, H. (2013) · Critical Care · doi:10.1186/cc11919 · Cited by 295
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury*
Martin, G. S., Mangialardi, R. J., Wheeler, A. P., Dupont, W. D., Morris, J. A., & Bernard, G. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200210000-00001 · Cited by 279
Should Unpublished Data Be Included in Meta-analyses?: Current Convictions and Controversies
Cook, D. J. (1993) · JAMA · doi:10.1001/jama.1993.03500210049030 · Cited by 259
The risk associated with hyperoncotic colloids in patients with shock
Schortgen, F., Girou, E., Deye, N., Brochard, L., & for the CRYCO Study Group (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1225-2 · Cited by 253
Salerno, F., Navickis, R. J., & Wilkes, M. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.007 · Cited by 220
Colloid solutions for fluid resuscitation
Bunn, F., Alderson, P., & Hawkins, V (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001319 · Cited by 218
Artero, A., Zaragoza, R., Camarena, J. J., Sancho, S., González, R., & Nogueira, J. M. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.12.004 · Cited by 201
Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury*
Quinlan, G. J., Mumby, S., Martin, G. S., Bernard, G. R., Gutteridge, J. M. C., & Evans, T. W. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000114574.18641.5d · Cited by 193
Colloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., & Roberts, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub5 · Cited by 191
Vincent, J.-L., Navickis, R. J., & Wilkes, M. M. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142574.00425.e9 · Cited by 185
Post Hoc Power: A Concept Whose Time Has Come
Onwuegbuzie, A. J., & Leech, N. L. (2004) · Understanding Statistics · doi:10.1207/s15328031us0304_1 · Cited by 177
Distribution of normal saline and 5% albumin infusions in septic patients
Ernest, D., Belzberg, A. S., & Dodek, P. M. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901000-00025 · Cited by 172
van der Heijden, M., Verheij, J., van Nieuw Amerongen, G. P., & Groeneveld, A. B. J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819cedfd · Cited by 166
QUINLAN, G. J., MARGARSON, M. P., MUMBY, S., EVANS, T. W., & GUTTERIDGE, J. M. C. (1998) · Clinical Science · doi:10.1042/cs0950459 · Cited by 160
New strategies for clinical trials in patients with sepsis and septic shock
Cohen, J., Guyatt, G., Bernard, G. R., Calandra, T., Cook, D., Elbourne, D., Marshall, J., Nunn, A., & Opal, S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00039 · Cited by 158
Heterogeneity and oxidation status of commercial human albumin preparations in clinical use*
Bar‐Or, D., Bar-Or, R., Rael, L. T., Gardner, D. K., Slone, D. S., & Craun, M. L. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000169876.14858.91 · Cited by 157
Gattas, D. J., Dan, A., Myburgh, J., Billot, L., Lo, S., & Finfer, S. R. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2840-0 · Cited by 155
Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery
Verheij, J., van Lingen, A., Beishuizen, A., Christiaans, H. M. T., de Jong, J. R., Girbes, A. R. J., Wisselink, W., Rauwerda, H., Huybregts, M. A. J. M., & Groeneveld, A. B. J. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0195-5 · Cited by 149
Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions
Haupt, M. T., & Rackow, E. C. (1982) · Critical Care Medicine · doi:10.1097/00003246-198203000-00004 · Cited by 142
Albumin Supplementation in the Critically Ill: A Prospective, Randomized Trial
Foley, E. F., Borlase, B. C., Dzik, W. H., Bistrian, B. R., & Benotti, P. N. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410180063012 · Cited by 142
Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials
Wiedermann, C. J., Dunzendorfer, S., Gaioni, L. U., Zaraca, F., & Joannidis, M. (2010) · Critical Care · doi:10.1186/cc9308 · Cited by 142
Efficacy of albumin supplementation in the surgical intensive care unit
GOLUB, R., Sorrento, J. J., Cantu, R., Nierman, D. M., Moideen, A. S., & Stein, H. D. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00017 · Cited by 126
Colloid solutions in the critically ill
Stockwell, M., Soni, N., & Riley, B. (1992) · Anaesthesia · doi:10.1111/j.1365-2044.1992.tb01941.x · Cited by 119
British National Formulary (BNF)
Thompson, D. (2005) · Cited by 111
Wise, J. (2013) · BMJ · doi:10.1136/bmj.f1738 · Cited by 110
Rackow, E. C., Mecher, C., Astiz, M. E., Griffel, M. I., Falk, J. L., & Weil, M. H. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00003 · Cited by 110
Vincent, J., Wilkes, M. M., & Navickis, R. J. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg233 · Cited by 104
Trof, R. J., Sukul, S. P., Twisk, J. W. R., Girbes, A. R. J., & Groeneveld, A. B. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1776-x · Cited by 104
Rubin, H., Carlson, S., DeMeo, M. T., Ganger, D. R., & Craig, R. M. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00009 · Cited by 95
Jacob, M., Chappell, D., Conzen, P. F., Wilkes, M. M., Becker, B. F., & Rehm, M. (2008) · Critical Care · doi:10.1186/cc6812 · Cited by 93
Panagiotou, O. A., Contopoulos-Ioannidis, D. G., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f707 · Cited by 89
Safety of gelatin for volume resuscitation—a systematic review and meta-analysis
Thomas-Rüddel, D. O., Vlasakov, V., Reinhart, K., Jaeschke, R., Rueddel, H., Hutagalung, R., Stacke, A., & Hartog, C. S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2560-x · Cited by 86
Patel, A., Waheed, U., & Brett, S. J. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2863-6 · Cited by 82
Self-citationCrystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency.
Metildi, L. A., Shackford, S. R., Virgilio, R. W., & Peters, R. M. (1984) · PubMed · Cited by 82
Gondos, T., Marjanek, Z., Ulakcsai, Z., Szabó, Z., Bogár, L., Károlyi, M., Gartner, B., Kiss, K., Havas, A., & Futó, J. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833b3504 · Cited by 76
The effects of hydroxyethyl starch solution in critically ill patients.
Palumbo, D., Servillo, G., D'Amato, L., Volpe, M. L., Capogrosso, G., ROBERTIS, E. D., Piazza, O., & Tufano, R. (2006) · PubMed · Cited by 53
Safety of human albumin based on spontaneously reported serious adverse events
von Hoegen, I., & Waller, C. (2001) · Critical Care Medicine · doi:10.1097/00003246-200105000-00021 · Cited by 51
Colloid solutions for fluid resuscitation
Bunn, F., Trivedi, D. P., & Ashraf, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001319.pub3 · Cited by 51
Wojtysiak, S. L., Brown, R. O., ROBERSON, D., Powers, D. A., & Kudsk, K. A. (1992) · Critical Care Medicine · doi:10.1097/00003246-199202000-00005 · Cited by 50
Veneman, T. F., Nijhuis, J. O., & Woittiez, A. J. J. (2004) · Wiener klinische Wochenschrift · doi:10.1007/bf03040900 · Cited by 47
The COASST study: Cost-effectiveness of albumin in severe sepsis and septic shock
Guidet, B., Jasso-Mosqueda, G., Priol, G., & Aegerter, P. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.11.005 · Cited by 43
Crystalloid Versus Colloid in Fluid Resuscitation of Patients with Severe Pulmonary Insufficiency
Metildi, L. A., Shackford, S. R., Virgilio, R. W., & Peters, R. M. (1985) · Survey of Anesthesiology · doi:10.1097/00132586-198502000-00057 · Cited by 41
Dolecek, M., Svoboda, P., Kantorová, I., Scheer, P., Sas, I., Bíbrová, J., Radvanová, J., & Radvan, M. (2009) · PubMed · Cited by 41
Bansal, M., Farrugia, A., Balboni, S., & Martin, G. S. (2013) · Current Drug Safety · doi:10.2174/15748863113089990046 · Cited by 28
(2011) · PubMed · Cited by 27
Vincent, J., Navickis, R. J., & Wilkes, M. M. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000159853.63127.0d · Cited by 20
McIntyre, L., Fergusson, D. A., Cook, D. J., Rowe, B. H., Bagshaw, S. M., Easton, D., Émond, M., Finfer, S. R., Fox‐Robichaud, A., Gaudert, C., et al. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.10.007 · Cited by 19
The PRECISE RCT: Evolution of an Early Septic Shock Fluid Resuscitation Trial
McIntyre, L., Fergusson, D. A., Rowe, B. H., Cook, D. J., Arabi, Y. M., Bagshaw, S. M., Émond, M., Finfer, S. R., Fox‐Robichaud, A., Gray, A. J., et al. (2012) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2011.11.003 · Cited by 19
Guidelines for the Use of Innovative Therapies in Sepsis
Cohen, I. L. (1993) · Critical Care Medicine · doi:10.1097/00003246-199303000-00032 · Cited by 9
Panagiotou, O. A., Contopoulos‐Ioannidis, D. G., & Ioannidis, J. P. A. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(15)70032-x · Cited by 8
Influence of different volume therapies on platelet function in the critically ill
Boldt, J., M�ller, M. J., Heesen, M. A., et al. (1996) · Intensive Care Medicine · doi:10.1007/s001340050216 · Cited by 8
Human Albumin Solution Resuscitation in Severe Sepsis and Septic Shock
Leitch, A., Craig, G. R., & Sadler, P. (2013) · Journal of the Intensive Care Society · doi:10.1177/175114371301400110 · Cited by 7
[Effect of different colloid volume-replacing solutions on a changed hemostasis system].
Bulanov, A. I., Vm, G., Shulutko, E. M., Vasil'ev, S. A., Борисовна, О. Е., Vn, M., Щербакова, О. В., Mamonov, V. E., & Strel'nikova, T. B. (2004) · PubMed · Cited by 3
Albumin for fluid resuscitation in patients with sepsis: what do we expect for?
Wang, Y., An, Y., & Ma, P. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130743 · Cited by 1
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“Patel et al (244) evaluated mixed populations, including resuscitation and maintenance.”
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation
Joffre, J., & Hellman, J. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2021.0027 · Cited by 337
Metadata
- Authors
- Patel, A., Laffan, M. A., Waheed, U., & Brett, S. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-07-22
- Volume
- 349
- Issue
- jul22 10
- Pages
- g4561-g4561
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2027555966
- Cited by
- 291
- References
- 124
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.